Abstract
Pure red cell aplasia is a rare complication of recombinant human erythropoietin (rHuEPO) treatment, which physicians should consider once the more frequent causes of hyporegenerative anemia have been excluded. To our knowledge, no pediatric cases have been described. In our patient, cyclosporin A treatment enabled a reduction in the number of transfusions and the risk of hyperimmunization. After transplantation, our patient’s hemoglobin level has remained normal and stable.
This is a preview of subscription content, log in via an institution to check access.
References
Bergrem H, Danielson BG, Eckardt K-U, Kurtz A, Stridsberg M (1993) A case of antierythropoietin antibodies following recombinant human erythropoietin treatment. In: Erythropoietin: molecular physiology and clinical application. Dekker, New York, pp 266–275
Peces R, Torre M de la, Alcázar R, Urra JM (1996) Antibodies against recombinant human erythropoietin in a patient with erythropoietin-resistant anemia. N Engl J Med 335:523–524
Prabhakar SS, Muhlfelder T (1997) Antibodies to recombinant human erythropoietin causing pure red cell aplasia. Clin Nephrol 47:331–335
Eckardt A-U, Casadevall N (2003) Pure red-cell aplasia due to antierythropoietin antibodies. Nephrol Dial Transplant 18:865–869
Bunn HF (2002) Drug-induced autoimmune red-cell aplasia. N Engl J Med 346:522–523
Krantz SB (1974) Pure red-cell aplasia. N Engl J Med 291:345–350
Kiely PDW, McGuckin CP, Collins DA, Bevan DH, Marsh JC (1995) Erythrocyte aplasia and systemic lupus erythematosus. Lupus 14:407–411
Agencia Española del Medicamento (2002) Comunicación sobre riesgos de medicamentos para profesionales sanitarios: Epoetina Alfa
Weber G, Gross J, Kromminga A, Loew HH, Eckardt K-U (2002) Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins. J Am Soc Nephrol 13:2381–2383
Cases A, Esforzado N, Mas M, Ricart MJ, Cruzado JM (2003) Aplasia pura de la serie roja asociada a anticuerpos neutralizantes frente a eritropoyetina inducida por epoetina alfa: una nueva forma de eritroblastopenia adquirida en pacientes urémicos. Nefrologia 23:266–270
Chng W, Tan L, Liu T (2003) Cyclosporine treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapy. Am J Kidney Dis 41:692–695
Duarte-Salazar C, Cazarin-Barrientos J, Goycoechea-Robles MV, Collazo-Jaloma J, Burgos-Vargas R (2000) Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A. Rheumatology 39:1155–1157
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alonso Melgar, A., Melgosa Hijosa, M., Pardo de la Vega, R. et al. Antierythropoietin antibody-induced pure red cell aplasia: posttransplant evolution. Pediatr Nephrol 19, 1059–1061 (2004). https://doi.org/10.1007/s00467-004-1489-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-004-1489-x